Fig. 4From: Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patientsKaplan–Meier curves for progression-free survival (PFS) of patients in the RT group who were platinum sensitive had a better PFS than those who were platinum resistantBack to article page